ns-MRAs: The Cardiovascular-Kidney-Metabolic Connection
Csaba P. Kovesdy, MD
Finnian R. Mc Causland, MD
ns-MRAs and eGFR Slope: The Kidney Perspective
Optimizing HF Outcomes Across the Spectrum: Emerging Evidence
Akshay S. Desai, MD
John McMurray, MD
Mastering MRA Monitoring: The Key to Success
Strategies for managing hyperkalemia in cardiorenal disease: A clinical dialogue defining a roadmap to improved outcomes
Gianluigi Savarese, MD
James Burton, DM, FRCP
Aaron Wong, MD
A multidisciplinary clinical dialogue: Optimizing long-term goals: practical approaches to novel potassium binder use in cardiorenal care
Challenges of managing hyperkalemia in HF patients with CKD while maintaining RAAS inhibitor therapy
Summarizing multidisciplinary strategies: Where do we go from here?
Screening for CKM Syndrome
Jürgen Floege, PhD
Definition and Staging of CKM Syndrome
Carolyn S. P. Lam, MBBS, PhD, MRCP, MS, FACC, FAMS, FESC
Comprehensive Management of Individuals with CKM Syndrome
Muthiah Vaduganathan, MD
Optimizing Care for Patients with CKM Syndrome: A Multidisciplinary Approach
Muthiah Vaduganathan, MD, MPH
Case-Based Learning and Future Directions
Jurgen Floege MD
Nonsteroidal MRAs: The CKD/T1D Potential
Hiddo L. Heerspink, PhD
MOA Deep Dive: The MRA Spectrum
Nonsteroidal MRAs: The CKD/T2D Advantage
Pardeep Jhund, MD, PhD
Loading...
We're glad to see you're enjoying PACE-CME… but how about a more personalized experience?
Press cancel to remain on PACE-CME. Press the link below or the continue button to keep going.